Skip to content

Clinical trials

Observational Insulin Resistance trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Observational Country / region: China Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20121
20131
20162
20173
20214
20221
20235
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9
Completed8
Recruiting5
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese Medical Association4
Shen Qu2
Beijing Anzhen Hospital1
Central South University1
Chinese PLA General Hospital1
Eli Lilly and Company1
First Affiliated Hospital Xi'an Jiaotong University1
Fudan University1
Guangzhou Women and Children's Medical Center1
Gui Xiaoting1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance25
Diabetes Mellitus, Type 27
Diabetes Mellitus6
Metabolic Diseases4
Polycystic Ovary Syndrome4
Critical Illness3
Obesity3
Diabetes Mellitus, Type 12
Diabetes, Gestational2
Endocrine System Diseases2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.